J.P.Morgan And Canaccord Genuity Are Confident That Vertex Pharmaceuticals Incorporated’s CF Drug Will Receive FDA Approval

On May 12, the FDA advisory committee recommended that the FDA approve Vertex Pharmaceuticals’ Orkambi therapy to treat cystic fibrosis. Shares of Vertex increased nearly 8% in pre-market trading following the announcement.